Alexander Shoushtari

51PUBLICATIONS
265CO-AUTHORS
Medical devicesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Nov 03, 2026
Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials.

|Oct 08, 2026
Universal Germline Genetic Testing after a Diagnosis of Cancer.

|Aug 25, 2026
Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma.

|Aug 13, 2026
Phase II Trial of First-line Axitinib plus Nivolumab in Patients with Advanced Mucosal Melanoma.

|Jul 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

Pageof 9

Frequent Collaborators

12 joint publications

Allison S Betof

11 joint publications

Michael Postow

7 joint publications

James William Smithy

7 joint publications

Jedd D Wolchok